Home
Search results “Seminar of cancer biology”
Cancer biology part 1 Introduction
 
19:18
For more information, log on to- http://shomusbiology.weebly.com/ Download the study materials here- http://shomusbiology.weebly.com/bio-materials.html This is an introductory video about cancer which encompasses various aspects of cancer. Source of the article published in description is Wikipedia. I am sharing their material. Copyright by original content developers. Link- http://en.wikipedia.org/wiki/Main_Page
Views: 53841 Shomu's Biology
29. Cancer I
 
46:31
MIT 7.013 Introductory Biology, Spring 2011 View the complete course: http://ocw.mit.edu/7-013S11 Instructor: Tyler Jacks In this lecture, Professor Jacks covers the fundamental definitions of different types of cancers, as well as their stages of progression. License: Creative Commons BY-NC-SA More information at http://ocw.mit.edu/terms More courses at http://ocw.mit.edu
Views: 40802 MIT OpenCourseWare
Cancer Biology 101
 
59:34
Thea Tlsty, UCSF Professor of Pathology, explains the biology of cancer; that cancer arises primarily through damage to the genetic program of our cells, how this leads to uncontrolled growth and invasion, how cancer intrudes upon and destroys adjacent or distant tissues, and how the inner workings of the cancer cell function. Series: "UCSF Osher Mini Medical School for the Public" [1/2012] [Health and Medicine] [Show ID: 22574]
An Answer to Cancer? Using the immune system to fight cancer -- Longwood Seminar
 
01:32:16
Oncologists are turning to a novel form of therapy to combat cancer: retraining or reengineering the immune system to quash tumor growth. In this seminar, hear from Harvard Medical School scientists and clinicians on the latest approaches that use the body’s own defenses to fight cancer. Speakers: - Arlene Sharpe, MD, PhD - Catherine J. Wu, MD - Jerome Ritz, MD - David F. McDermott, MD Like Harvard Medical School on Facebook: https://goo.gl/4dwXyZ Follow on Twitter: https://goo.gl/GbrmQM Follow on Instagram: https://goo.gl/s1w4up Follow on LinkedIn: https://goo.gl/04vRgY Website: https://hms.harvard.edu/
Views: 12270 Harvard Medical School
81st Symposium - Targeting Cancer - Robert Weinberg
 
22:57
2016 Cold Spring Harbor Laboratory Symposium on Quantitative Biology Targeting Cancer Attend a CSHL meeting: http://bit.ly/cshlmtg Train at a CSHL course: http://bit.ly/cshlcourses Subscribe to receive new video notifications: http://bit.ly/2aVrXaM CONNECT WITH US Blog: http://bit.ly/cshlcxblog Twitter: http://bit.ly/cshlmctwitter Instagram: http://bit.ly/cshlmcinsta Facebook: http://bit.ly/cshlmcfb Website: http://bit.ly/cshlmtgcrs Interview with Robert Weinberg Beatson Institute, Cancer Research, UK Interviewer: Jan Witkowski Cold Spring Harbor Laboratory, NY
Views: 2401 CSHL Leading Strand
Jiři Bártek, Professor of Cancer Biology
 
00:56
Jiři Bártek, new professor at Karolinska Institutet presents his research mission.
[Seminar Series] Anti-cancer strategy by modulation of cancer cell signaling, Introduction
 
03:58
Dr. Sangwon Kang is a professor at Ewha woman's university, department of life science. And he has been working on cell signaling research, mainly on the ROS and redox signaling in cells. Professor Kang will give a lecture about the new type of cancer treatment. Which use ROS and redox signaling modulation to kill cancer cells. For example, there is peroxiredoxin 2 in our body and it protects VEGFR2 by removing ROS. If we eliminate peroxiredoxin 2, VEGF signal cannot be transmitted to cancer cells and it causes damage to cells.
Views: 482 Biology and beyond
Prof. Douglas Hanahan Hallmarks of Cancer - Applications  - Technion Integrated Cancer Center
 
24:40
Prof. Douglas Hanahan - Swiss Federal Institute of Technology Hallmarks of Cancer - Applications to Cancer Medicine At the Inauguration of the Technion Integrated Cancer Center. Nov. 20, 2016
Views: 3232 Technion
[Seminar Series] Anti-cancer Strategy targeting cancer cell signaling, Introduction
 
02:46
This is the introductory video for Dr. Junseong Park's presentation.
Views: 158 Biology and beyond
Cancer Seminar
 
19:27
Tom Laughlin discusses a new seminar series he will be giving based his book "The 6 Psychological Factors that can Lead to Cancer". This will be a four week - 1 hour per week - online seminar where attendees can ask questions and interact with Tom. If you have cancer, or have a loved one who has cancer, or are worried about getting cancer, you don't want to miss this seminar series.
Views: 12892 Tom Laughlin
5th Biofans Conference - Cancer biology & latest applications in cancer treatment
 
01:13:03
Dr. Mona Anas , "Demonstrator of Medical Biochemistry and Molecular Biology, Cancer Biology Department, National Cancer Institute, Cairo University." Lecture Title: Cancer biology & latest applications in cancer treatment Lecture Data: http://riffhold.com/R2D Conference organized by (SCITA Team) , for more information: ■ Facebook page: https://www.facebook.com/scitateam ■ Twitter: https://twitter.com/scitateam ■ Website: https://scitateam.com
Views: 112 SCITA
81st Symposium - Targeting Cancer - Elaine Mardis
 
19:19
2016 Cold Spring Harbor Laboratory Symposium on Quantitative Biology Targeting Cancer Interview with Elaine Mardis Washington University School of Medicine, MO Interviewer: Richard Sever Cold Spring Harbor Laboratory Press, NY Attend a CSHL meeting: http://bit.ly/cshlmtg Train at a CSHL course: http://bit.ly/cshlcourses Subscribe to receive new video notifications: http://bit.ly/2aVrXaM CONNECT WITH US Blog: http://bit.ly/cshlcxblog Twitter: http://bit.ly/cshlmctwitter Instagram: http://bit.ly/cshlmcinsta Facebook: http://bit.ly/cshlmcfb Website: http://bit.ly/cshlmtgcrs
Views: 1293 CSHL Leading Strand
Genes Gone Wild: The Biology of Human Cancer
 
50:10
Presented by Brittany Michel and Thomas Howard DayCon 2015: Bio-Medley June 6, 2015 **See http://sitn.hms.harvard.edu/daycon/ for complete Lecture Slides **
Views: 1159 SITN Boston
Reinhard Laubenbacher
 
01:01:25
Seminar on Cancer systems biology by Reinhard Laubenbacher organized by BCB Lab at iastate. More information about Reinhard Laubenbacher can be found at http://www.vbi.vt.edu/faculty/personal/Reinhard_Laubenbacher and BCB Lab : http://lab.bcb.iastate.edu/.
Views: 98 bcblabseminar
Part 6 - Rick Simpson's CRUSH CANCER WITH HEMP AND TRUTH - Free Internet Seminar
 
09:54
Dr. Robert Melamede, Ph.D, Associate Professor of Biology at University of Colorado discusses cannabinoids and cancer. (Clips courtesy of Cannabis TV and Safeaccess - YOUTUBE) Rick Simpson speaks to the people of the world in his CRUSH CANCER WITH HEMP AND TRUTH FREE INTERNET SEMINAR, all about curing cancer and other diseases with hemp oil. Please check our playlists to play the entire seminar from start to finish. Permission to download, copy, and repost is granted and also encouraged so that it may be seen by the largest global audience possible. Please share with everyone you know. For more information on Rick's courageous effort to eliminate cancer with man's oldest known and safest medication... please visit us at http://www.phoenixtears.ca or watch and download your FREE copy of RUN FROM THE CURE: The Rick Simpson Story at http://www.phoenixtearsmovie.com Produced and Directed by Christian Laurette for Phoenix Tears Special thanks to M.U.M.M. http://mumm.ca/ Dr. Robert Melamede, Ph.D, Associate Professor of Biology at University of Colorado discusses cannbinoids and cancer.
Views: 17361 chrychek
Biology Human Health & Diseases part 20 (Cancer cause) class 12 XII
 
12:45
Biology Human Health & Diseases part 20 (Cancer cause) class 12 XII
Views: 36735 ExamFear Education
What is cancer? In Hindi
 
09:03
Video concept and script: Amaya Mangaldas
Cancer immunology (immune response against cancer)
 
17:06
For more information, log on to- http://shomusbiology.weebly.com/ Download the study materials here- http://shomusbiology.weebly.com/bio-materials.html Source of all articles published in description is Wikipedia. Thanks to original content developers. Link- http://en.wikipedia.org/wiki/Main_Page Cancer immunology is the study of interactions between the immune system and cancer cells (also called tumors or malignancies). It is a growing field of research that aims to discover innovative cancer immunotherapies to treat and retard progression of the disease. The immune response, including the recognition of cancer-specific antigens is of particular interest in the field as knowledge gained drives the development of new vaccines and antibody therapies. For instance in 2007, Ohtani published a paper finding tumour infiltrating lymphocytes to be quite significant in human colorectal cancer.[1] The host was given a better chance at survival if the cancer tissue showed infiltration of inflammatory cells, in particular those prompting lymphocytic reactions. The results yielded suggest some extent of anti-tumour immunity is present in colorectal cancers in humans. Over the past 10 years there has been notable progress and an accumulation of scientific evidence for the concept of cancer immunosurveillance and immunoediting based on (i) protection against development of spontaneous and chemically-induced tumors in animal systems and (ii) identification of targets for immune recognition of human cancer. Cancer immunosurveillance is a theory formulated in 1957 by Burnet and Thomas, who proposed that lymphocytes act as sentinels in recognizing and eliminating continuously arising, nascent transformed cells.[2][3] Cancer immunosurveillance appears to be an important host protection process that decreases cancer rates through inhibition of carcinogenesis and maintaining of regular cellular homeostasis.[4] It has also been suggested that immunosurveillance primarily functions as a component of a more general process of cancer immunoediting.
Views: 22980 Shomu's Biology
Karl-Johan Malmberg - Harnessing Natural Killer Cells in Cancer Immunotherapy
 
29:14
Karl-Johan Malmberg Professor and Co-Director Department of Immunology Oslo University Hospital Oslo Norway speaks on "Harnessing Natural Killer Cells in Cancer Immunotherapy". This movie has been recorded by ICGEB Trieste at "STREAM Consortium Steering Committee", ICGEB Trieste Seminar Room.
Views: 1266 Icgeb
SOLUTIONS with/in/sight: Masterclass with Robert Weinberg
 
01:07:35
KI biologist and cancer research pioneer Robert Weinberg discovered the first human oncogene and literally wrote the (text)book on cancer. His contributions and mentorship in the field have inspired multiple generations of researchers to apply their skills and talents to the ongoing fight against this deadly disease. Following his masterclass presentation about the mechanisms of metastasis, Professor Weinberg sat down with former trainee Tyler Jacks, now the director of the Koch Institute, for an intimate conversation about their shared passion for cancer research and professional journeys at MIT. This program was the second of five special with/in/sight events celebrating our fifth anniversary and highlighting the pillars of progress in MIT's interdisciplinary approach to cancer research
Views: 2842 KochInstituteMIT
Cancer Revealed: How the Immune System Sees and Destroys Tumors, with Jeffrey Weber
 
01:02:36
On June 16, 2015, Jeffrey S. Weber, M.D., Ph.D., discussed the cancer immunity cycle and the importance of antigen release and presentation to maximize the potential of immunotherapies. Jeffrey S. Weber, M.D., Ph.D., is a senior member, director of the Donald A. Adam Comprehensive Melanoma Research Center of Excellence (MRCoE), and professor in the department of oncologic sciences at Moffitt Cancer Center. As a tumor immunologist and immunotherapist, he focuses on translational clinical trials, including the development of novel trials in melanoma. His laboratory interests are in the monitoring and characterization of T cell responses in patients with cancer, and the establishment of in vitro models to facilitate the understanding of how immune modulation via abrogating and activating antibodies amplifies adaptive immunity in patients. Dr. Weber earned his Ph.D. in molecular cell biology from The Rockefeller University in 1979 and his M.D. from New York University Medical Center in 1980. Dr. Weber has published more than 100 articles in the top peer-reviewed journals in his field. This webinar, which is part of the Cancer Research Institute's Breakthroughs in Cancer Immunotherapy Webinar Series, was generously supported by Amgen. It is offered free to the public and feature informative updates from leaders in cancer immunotherapy, followed by a moderated Q&A. For more information on this webinar, or to register for upcoming webinars, please visit www.cancerresearch.org/webinars.
Seminar: Engineering Biology and Medicine at Small Scales
 
01:02:27
Dartmouth's Jones Seminars on Science, Technology, and Society. "Engineering Biology and Medicine at Small Scales: From Cell Manipulation, Molecular Screening to Early Cancer Detection" John X.J. Zhang, Associate Professor, University of Texas at Austin Friday, April 26, 2013
Pamela Martin, Cancer Biology Lab Manager
 
03:37
Vanderbilt Medical Center's 2007 Commodore Award was presented to Pamela Martin, Lab Manager for Cancer Biology. http://www.vanderbilt.edu/myvu/news/2007/09/26/rocky-alvey-and-pamela-martin-receive-commodore-awards.47414 http://www.mc.vanderbilt.edu/
Views: 2084 ChptrHouse
Killing Cancer with Cannabis
 
01:28:00
Killing Cancer with Cannabis Museum of Science | Boston, MA October 1st, 2018 The Museum of Science welcomes David "Dedi" Meiri, PhD, a biologist and director of the Laboratory of Cancer Biology and Cannabinoid Research at Technion-Israel Institute of Technology, and Bonni Goldstein, MD, a physician who specializes in cannabis medicine, medical director of Canna-Centers, and author of Cannabis Revealed: How the world's most misunderstood plant is treating everything from chronic pain to epilepsy. In conversation with Kara Miller, host and executive editor of WGBH Radio's Innovation Hub. Funding provided by the Reno Family Foundation Fund. This program is free thanks to the generosity of the Lowell Institute.
Views: 109 BostonMOS
Panning for Therapeutic Gold: Cancer Genetics — Longwood Seminar
 
01:29:10
The end of 2011 marked the 40-year anniversary of President Nixon declaring the War on Cancer. Though a cure has not yet been discovered, the understanding of genetics is revolutionizing cancer research and improving the ways in which we can battle one of medicine's most challenging diseases. At this April 3, 2012, seminar, Harvard researchers will discuss how far we have come and where the field is heading in revealing the causes of cancer and our potential to develop transformative therapies. Learn more about the Longwood Seminars by visiting hms.harvard.edu/public/longwood.
San Antonio Breast Cancer Symposium
 
04:55
SABCS is designed to provide state-of-the-art information on the experimental biology, etiology, prevention, diagnosis, and therapy of breast cancer and premalignant breast disease, to an international audience of academic and private physicians and researchers. Learn more at www.AACR.org/SABCS17.
Structural biology, Proteomics & Cancer Symposium: 11 Signal Transduction and Cancer
 
48:12
Signal Transduction and Cancer: Characterization of the TSC/Rheb/mTOR signaling pathway Prof. Fuyu Tamanoi-Dept. of Microbiology, Immunology & Molecular Genetics, Signal Transduction Program Area, Jonsson Comprehensive Cancer Center Structural biology, Proteomics & Cancer Symposium: The symposium is part of a workshop (March 6-8) that will bring together leaders from VNU-HCMC and UCLA, and is co-sponsored by the Center for Global Mentoring (CGM) at UCLA. The mission of CGM is to partner with international universities to foster excellence in mentoring for researchers in the basic sciences. The symposium, on March 7th, will include scientific presentations from both VNU and keynote UCLA faculty. All faculties and students at VNU are welcome to attend the seminars. The major goals of the workshop are to establish contacts with students and faculties, and to strengthen collaborations in the areas of structural biology, proteomics and cancer
John Schiller (NCI at NIH) 1: Human Papillomavirus (HPV) Vaccines to Prevent Cancer
 
32:44
https://www.ibiology.org/human-disease/hpv John Schiller provides an overview of HPV virus and infection, compares the three FDA approved vaccines against HPV, and explains the endpoints used in the clinical trials to prove vaccine efficacy. Talk Overview: Human Papillomavirus (HPV) causes 5% of all cancers worldwide, and the first vaccine against HPV was approved in 2006. In this seminar, Dr. John Schiller provides an overview of HPV virus and infection, compares the three FDA approved vaccines against HPV, and explains the endpoints used in the clinical trials to prove vaccine efficacy. After a decade of using the vaccine, retrospective studies now allow us to evaluate the possibility of using single-dose vaccination, which could lead to an increase in the general use of the vaccine (implementation), and improve HPV-related cancer prevention. In his second seminar, Schiller discusses the high efficacy of HPV vaccine, which is exceptionally good at producing neutralizing antibodies and also benefits from the low mutation rate of HPV. Coming to a better understanding of the efficacy of the HPV vaccine will provide evidence to support single-dose vaccination and aids in the development of new vaccines. Speaker Biography: Dr. John Schiller is a National Institute of Health (NIH) distinguished investigator and a professor at the National Cancer Institute at the NIH. Schiller completed his bachelor’s degree in molecular biology at the University of Wisconsin-Madison (1975), and received a doctorate degree in Microbiology at the University of Washington in Seattle (1982). Schiller continued his training at the Laboratory of Cellular Oncology as a National Research Service Award postdoctoral fellow. He became a senior investigator in 1986, and in 2016 he was designated as an NIH Distinguished Investigator. For his scientific contributions, Schiller received the National Medal of Technology and Innovation (2012), the American Society for Microbiology’s Joseph Public Health Award (2017), and the Lasker-DeBakey Clinical Medical Research Award (2017). Learn more about Schiller’s research at his lab website: https://ccr.cancer.gov/Laboratory-of-Cellular-Oncology/john-t-schiller
Views: 2070 iBiology
ENGAGE Seminars 2014 - Kate Connor - CARTing away Breast Cancer
 
10:52
Kate Connor is a PhD student in the 'Cancer Biology and Therapeutics lab' in UCD. In her presentation titled 'CARTing away Breast Cancer', Kate describes how her research is investigating the role of a protein called CART in breast cancer and determining if new drugs to target CART could lead to new treatments. For more information about the ENGAGE Seminars contact Craig Slattery (craig.slattery@ucd.ie) or Mary Gallagher-Cooke (m.gallagher@ucd.ie).
Views: 191 SBBSUCD
Structural biology, Proteomics & Cancer Symposium: 10 Computational Biophysics and Medicine in VN
 
29:13
Computational Biophysics and Medicine in Vietnam: Past, Present and Future Prof. Mai Suan Li - Institute for Computational Science and Technology, Ho Chi Minh city, VN; Institute of Physics, Polish Academy of Sciences, Poland Structural biology, Proteomics & Cancer Symposium: The symposium is part of a workshop (March 6-8) that will bring together leaders from VNU-HCMC and UCLA, and is co-sponsored by the Center for Global Mentoring (CGM) at UCLA. The mission of CGM is to partner with international universities to foster excellence in mentoring for researchers in the basic sciences. The symposium, on March 7th, will include scientific presentations from both VNU and keynote UCLA faculty. All faculties and students at VNU are welcome to attend the seminars. The major goals of the workshop are to establish contacts with students and faculties, and to strengthen collaborations in the areas of structural biology, proteomics and cancer
Zoology: Cancer Biology
 
59:01
This Lecture talks about Zoology: Cancer Biology.
Views: 1092 Cec Ugc
How do cancer cells behave differently from healthy ones? - George Zaidan
 
03:51
View full lesson: http://ed.ted.com/lessons/how-do-cancer-cells-behave-differently-from-healthy-ones-george-zaidan How do cancer cells grow? How does chemotherapy fight cancer (and cause negative side effects)? The answers lie in cell division. George Zaidan explains how rapid cell division is cancer's "strength" -- and also its weakness. Lesson by George Zaidan, animation by TED-Ed.
Views: 957673 TED-Ed
[Seminar Series] Anti-cancer strategy targeting cancer stem cell, Introduction
 
06:30
Dr. Kang Seokgu will give us a lecture about the significance and implication of cancer stem cells in treatment of intractable malignant brain tumors.
Views: 128 Biology and beyond
Molecular Genetics and Cancer
 
05:23
https://www.ibiology.org/cell-biology/cell-adhesion-signaling-cancer/ Mary Beckerle explains that molecular genetics make it possible to determine which genes are turned on or off in different tumors and she discusses the implications for cancer treatment. See the whole lecture at www.ibioseminars.org
Views: 5382 iBiology
Structural biology, Proteomics & Cancer Symposium: 04 VNU HCM Biomedical Science Program
 
20:10
VNU-HCM Biomedical Science Program-Prof. Tran Linh Thuoc President of University of Science, VNU-HCM, VN Structural biology, Proteomics & Cancer Symposium: The symposium is part of a workshop (March 6-8) that will bring together leaders from VNU-HCMC and UCLA, and is co-sponsored by the Center for Global Mentoring (CGM) at UCLA. The mission of CGM is to partner with international universities to foster excellence in mentoring for researchers in the basic sciences. The symposium, on March 7th, will include scientific presentations from both VNU and keynote UCLA faculty. All faculties and students at VNU are welcome to attend the seminars. The major goals of the workshop are to establish contacts with students and faculties, and to strengthen collaborations in the areas of structural biology, proteomics and cancer
[Seminar Series] Anti-cancer strategy for glioblastoma multiforme by targeting cancer stem cells
 
15:27
Presented by Nuri Oh for review of Prof. Seok-gu Kang's lecture on cancer stem cell in glioblastoma multiforme
Views: 753 Biology and beyond
02- Interest in Cancer Biology - Interview with Dr. Frank Slack
 
01:51
For additional information visit http://www.cancerquest.org/frank-slack-interview. Dr. Frank Slack is Professor of Molecular, Cellular & Developmental Biology at Yale University. Dr. Slack's research is directed at understanding the role of microRNAs in cancer, both as possible treatments and as potential targets of therapy. MicroRNAs are small RNA molecules that are normally found in cells. They are able to control the activity of genes and alter the translation of messenger RNAs (mRNAs). The microRNAs present in a normal cell are not exactly the same as those in a cancer cell and that difference could be critical for many cancer types. In this interview, Dr Slack discusses the background to his interest in cancer biology. To learn more about cancer and watch additional interviews, please visit the CancerQuest website at http://www.cancerquest.org.
Views: 249 CancerQuest
Seminar: Engineering Proteins for Cancer Imaging and Therapy
 
51:43
Dartmouth's Jones Seminars on Science, Technology, and Society "Engineering Proteins for Cancer Imaging and Therapy." Sarah Moore, Assistant Professor of Engineering, Smith College. Friday, January 16, 2015.
Cancer Genetics and Precision Cancer Therapy - Life Sciences Forum
 
01:43:45
Please join us as MITCNC hosts the second Bay Area with/in/sight lecture series from the David H. Koch Institute for Integrative Cancer Research at MIT. We invite you to enjoy the networking reception, mingle with fellow guests and scientists, and join us for a series of informative talks about recent exciting progress in the areas of cancer genetics and new treatments based on our understanding of cancer genes. The event will showcase research from MIT's Dr. Tyler Jacks, PhD, David H. Koch Professor of Biology, Investigator at the Howard Hughes Medical Institute, and Director of the Koch Institute for Integrative Cancer Research. Professor Jacks will discuss work from his laboratory on the development of novel therapeutic strategies that target common genetic alterations in many human cancers. Dr. Jacks will be joined by Dr. Kevin Shannon, MD, who is the Roma and Marvin Auerback Distinguished Professor in Pediatric Oncology at the University of California, San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center. Dr. Shannon, a physician-scientist, will discuss the challenges and opportunities of new cancer medicines from a clinical perspective. Rounding out the program will be Dr. Jeffrey Settleman, PhD. Dr. Settleman is Senior Director of Discovery Oncology at Genentech. He will present research from his own laboratory at Genentech as well as review new cancer therapeutic programs at the company. The panel discussion will be moderated by Dr. Laura D. Attardi, PhD, an Associate Professor in the Departments of Radiation Oncology & Genetics, at Stanford University School of Medicine.
Top Cancer Centers - DatStat Online Seminar
 
01:03:01
Data managers at two NCI-designated cancer research facilities are using online data capture to facilitate groundbreaking research. Carol Lowenstein of Dana-Farber Cancer Institute discusses the CanSeq Initiative, which seeks to "develop a model for the integration of germline and somatic genome sequencing into the care of cancer patients." The study is made up of three sub-projects -- focused on lab, clinical and social/behavioral aspects -- and involves three types of subjects (physicians, patients, and committee members) with multiple study arms. Scott Sutherland and David Rogers of Fred Hutchinson Cancer Research Center discuss the double data entry scripts and call center management software they have developed to work in conjunction with DatStat software for data capture and workflow management. They also highlight three current studies: TALK Smoking Cessation Study, Sjogren's Syndrome Biomarkers Study, and PLAT01 Cellular Immunotherapy Study. These studies require varying combinations of workflow management, multi-mode surveys, CRFs and eCRFs, audit trails, and adverse event tracking.
Views: 174 DatStat
Cell Biology: How Do Cells Make Decisions?
 
01:25:50
The UCSF community honored J. Michael Bishop's 11-year tenure as chancellor of UCSF with an all-day symposium addressing vexing biomedical issues at the Mission Bay campus on June 7. The event focused on four topics: malaria, cell biology, cancer and neurosciences. As chancellor, Bishop, MD, a Nobel laureate, led UCSF through one of its most expansive periods of growth and achievement, including development of the Mission Bay campus. In this segment of the symposium, titled "Cell Biology: How Do Cells Make Decisions?," the moderator is Marc Kirschner, PhD, John Franklin Enders University Professor of Systems Biology, Department of Systems Biology, Harvard University; the speaker is Richard Losick, PhD, Maria Moors Cabot Professor of Biology, Department of Molecular and Cellular Biology, Harvard University; and panelists are Hana El Samad, assistant professor, Biochemistry & Biophysics, UC Berkeley/UCSF Graduate Group in Bioengineering; and Jonathan Weissman, PhD, professor of Cellular and Molecular Pharmacology and of Biochemistry and Biophysics at UCSF.
Structural biology, Proteomics & Cancer Symposium: 08 Discussion
 
24:09
Discussion Structural biology, Proteomics & Cancer Symposium: The symposium is part of a workshop (March 6-8) that will bring together leaders from VNU-HCMC and UCLA, and is co-sponsored by the Center for Global Mentoring (CGM) at UCLA. The mission of CGM is to partner with international universities to foster excellence in mentoring for researchers in the basic sciences. The symposium, on March 7th, will include scientific presentations from both VNU and keynote UCLA faculty. All faculties and students at VNU are welcome to attend the seminars. The major goals of the workshop are to establish contacts with students and faculties, and to strengthen collaborations in the areas of structural biology, proteomics and cancer
Lecture on the topic of Cancer Biology by Dr. Alok Chandra Bharti in INSPIRE Camp 2016 Part 1
 
34:05
Lecture on the topic of Cancer Biology by Dr. Alok Chandra Bharti in INSPIRE Camp 2016 at RKGEC
Views: 72 RKGEC Official
Mary Beckerle (University of Utah) Part 1: Adhesion, Signaling and Cancer
 
36:04
Cell-substratum adhesion is mediated by integrins, a family of transmembrane, heterodimeric, extracellular matrix receptors that are concentrated at focal adhesions. Integin engagement influences a variety of signaling pathways and regulates cell behaviors including motility, proliferation, and survival. Disturbance of normal integrin function is associated with a variety of pathologic conditions including cancer. In the first segment of my seminar, I provide a broad overview of the cancer problem for a lay audience. Advances in our understanding of cancer as a genetic disease are discussed. The influence of cell adhesion on control of cell growth is reviewed. See more at http://www.ibiology.org
Views: 25540 iBiology
Cancer and stem cells – the cells of possibilities? (Life Science Lunch)
 
39:35
What are stem cells, where do we find them and what are their roles? How can we use knowledge about stem cells in research and treatment of diseases? Three quick talks by Ragnhild Eskeland, Thomas Küntziger and Steven Wilson shed some light on this debated topic. -------------- (1) "Stem cells – endless possibilities?" Principal Investigator, Ragnhild Eskeland, Department of Biosciences, Faculty of Mathematics and Natural Sciences, University of Oslo (UiO) She will give us the facts about stem cells in general and tell us how they relate to cancer. She will also tell us why stem cells are so much debated. -------------- (2) "Understanding the chromosome dance" Associate Professor, Thomas Küntziger, Department of Oral Biology, Faculty of Dentistry, University of Oslo (UiO) He will tell us about the role of the protein AKAP95 in the accurate distribution of the chromosomes between the two daughter cells during cell division (mitosis). Mistakes in this process are known to give rise to cancer cells. Thomas Küntziger currently holds funding from the Norwegian Cancer Society for his research project on the role of a protein (AKAP95) in a surveillance mechanism called the spindle assembly checkpoint. -------------- (3) "Innovative approaches for targeting stem cells in cancer" Associate Professor, Steven Wilson, the Cancer–Stem cell innovation center (SFI-CAST), Department of chemistry, Faculty of Mathematics and Natural Sciences, University of Oslo (UiO) He will talk about approaches and technologies for analyzing stem/cancer cells, to develop diagnostic approaches and therapeutics. Steven Ray Wilson has a PhD in chemistry, within the field of analytical chemistry. His main interests are developing technology for diagnostic purposes within cancer, typically in the framework of stem-related signal pathways such as the Hedgehog and Wnt pathway. A central focus is developing tools that can analyze extremely small samples. -------------- http://www.ub.uio.no/kurs-arrangement/arrangementer/ureal/science-debate/2016/161116LILcancer.html
Structural biology, Proteomics & Cancer Symposium: 09 The amyloid state of proteins
 
28:35
The amyloid state of proteins, and connections to diseases including cancer Prof. David Eisenberg-Director of CGM; Director of Institute for Genomics and Proteomics, UCLA, USA Structural biology, Proteomics & Cancer Symposium: The symposium is part of a workshop (March 6-8) that will bring together leaders from VNU-HCMC and UCLA, and is co-sponsored by the Center for Global Mentoring (CGM) at UCLA. The mission of CGM is to partner with international universities to foster excellence in mentoring for researchers in the basic sciences. The symposium, on March 7th, will include scientific presentations from both VNU and keynote UCLA faculty. All faculties and students at VNU are welcome to attend the seminars. The major goals of the workshop are to establish contacts with students and faculties, and to strengthen collaborations in the areas of structural biology, proteomics and cancer
Cancer-host crosstalk through endogenous and exogenous extracellular miRNA
 
01:09:58
Emily Wang of UCSD presents an overview of her lab's work studying the role of extracellular microRNAs in breast cancer. This web seminar was presented as part of the Extracellular RNA Communication Consortium (ERCC) seminar series on 01 September 2016.
Views: 112 Roger Alexander
Structural biology, Proteomics & Cancer Symposium: 03 Welcome by UCLA and HCMUS
 
06:53
Welcome by UCLA-CGM-Prof. David Eisenberg Director of CGM; Director of Institute for Genomics and Proteomics, UCLA, USA Welcome by HCMUS, VNU-HCM-Prof. Tran Linh Thuoc President of University of Science, VNU-HCM, VN Structural biology, Proteomics & Cancer Symposium: The symposium is part of a workshop (March 6-8) that will bring together leaders from VNU-HCMC and UCLA, and is co-sponsored by the Center for Global Mentoring (CGM) at UCLA. The mission of CGM is to partner with international universities to foster excellence in mentoring for researchers in the basic sciences. The symposium, on March 7th, will include scientific presentations from both VNU and keynote UCLA faculty. All faculties and students at VNU are welcome to attend the seminars. The major goals of the workshop are to establish contacts with students and faculties, and to strengthen collaborations in the areas of structural biology, proteomics and cancer